Catalyst4, Inc.
10% Owner at MapLight Therapeutics, Inc. (MPLT)
Purchase track record
Not enough history. Based on 1 purchase with a full 90 days of price history.
—
Avg. 90-day return+15.7%
vs. S&P 500+14.2%
Beat the market100%
Paper profit on buys−$60.3M
Total bought / sold$158M / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 18SEC | MPLTMapLight Therapeutics, Inc. | Buy | 4,400,00025,306,689 held (+21%) | $11.38 | $50.1M | -22.4% |
| Jul 30SEC | MPLTMapLight Therapeutics, Inc. | Buy | 141,08819,838,552 held (+1%) | $10.74 | $1.5M | -17.8% |
| Jul 30SEC | MPLTMapLight Therapeutics, Inc. | Buy | 65,13719,903,689 held (+0%) | $11.69 | $761K | -24.5% |
| Jul 30SEC | MPLTMapLight Therapeutics, Inc. | Buy | 3,00019,906,689 held (+0%) | $12.63 | $38K | -30.1% |
| Jul 30SEC | MPLTMapLight Therapeutics, Inc. | Buy | 1,000,00020,906,689 held (+5%) | $13.00 | $13.0M | -32.1% |
| Oct 29SEC | MPLTMapLight Therapeutics, Inc. | Buy | 5,441,17619,697,464 held (+38%) | $17.00 | $92.5M | -48.1% |
- Buy
10% Owner Catalyst4, Inc. bought $50.1M of MPLT at $11.38 — raises the stake by 21%.
- Buy
10% Owner Catalyst4, Inc. bought $92.5M of MPLT at $17.00 — first open-market purchase in our records; raises the stake by 38%.